16 - 22 June 2018
These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts
NICE say yes to Ocrevus for RRMS
NICE has approved Ocrevus (ocrelizumab) as a treatment for people with active relapsing remitting MS who are unable to take alemtuzumab (Lemtrada). NICE's decision covers England and Wales. Northern Ireland usually follows NICE decisions. The SMC are expected to publish their guidance for Scotland in July
Source: Pharma Times
Review of medical cannabis
The Home Secretary has announced a review of the use and potential harms of medicinal cannabis. This could lead to a rescheduling of its use as a treatment. The government have no plans to legalise or decriminalise the drug for recreational use.
MS Trust link: Cannabis
Tysabri in SPMS
The ADAMS project
25/05/2022 - 00:00
Dr Benjamin Jacobs spoke to us about a new study on the genetics of MS in people from minority ethnic backgrounds which may eventually shed light on why MS can be more severe for Black and Asian people.
Roxy's journey to diagnosis
16/05/2022 - 00:00
Roxy talks about her MS journey and the importance of sharing her own experiences to ensure that others don’t face the same challenges when receiving a diagnosis.
Lis' MS journey: one woman and her bike
04/05/2022 - 00:00
In May 2022, Lis will be heading off on her 5,000 mile cycling challenge. She shares how the idea came about and discusses why the support of the MS Trust was invaluable following a multiple sclerosis diagnosis.
Sign up for updates from us
Keep up-to-date with the latest MS news, explore new research, read the stories of people living with MS, find out practical tips from MS experts, and discover exciting fundraising opportunities.